Found 13 matching trials
Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) PHASE2 This is a study to evaluate the safety and efficacy of Losmapimod in treati...
Show More Location
University of California Irvine
Learn More & Join Trial
Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen. PHASE2 The main purpose of this study is to determine the effect of Losmapimod on ...
Show More Location
Cambridge University Hospitals NHS Foundation Trust
Learn More & Join Trial
Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH) PHASE3 This is a study to evaluate the safety and efficacy of losmapimod in treati...
Show More Location
University of California Irvine
Learn More & Join Trial
Losmapimod Safety and Efficacy in COVID-19 PHASE3 The therapeutic hypothesis for the use of losmapimod in COVID-19 disease is...
Show More Location
University of California Irvine - Irvine Medical Center
Learn More & Join Trial
A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging PHASE2 This study is being conducted to assess the potential anti-inflammatory eff...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 This is a randomised, double-blind, parallel-group, multi-centre study eval...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin PHASE1 This will be a double-blind, 4-period, randomized, cross-over study conduct...
Show More Location
GSK Investigational Site
Learn More & Join Trial
PK Study of IV Formulation of GW856553 PHASE1 The purpose of this study is to evaluate the safety of an IV infusion of GW...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD). PHASE2 Randomised, double-blind, parallel-group, multi-centre study evaluating thr...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets PHASE1 This is a study to assess the relative bioavailability and the effect of fo...
Show More Location
PPD Phase I Clinic
Learn More & Join Trial